Matches in Wikidata for { <http://www.wikidata.org/entity/Q98604751> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q98604751 description "clinical trial" @default.
- Q98604751 description "ensayo clínico" @default.
- Q98604751 description "ensayu clínicu" @default.
- Q98604751 description "klinisch onderzoek" @default.
- Q98604751 description "клінічне випробування" @default.
- Q98604751 description "临床试验" @default.
- Q98604751 name "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 name "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 type Item @default.
- Q98604751 label "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 label "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 prefLabel "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 prefLabel "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 P1050 Q98604751-7B7E2D02-6999-4250-9599-2EEDA768815D @default.
- Q98604751 P1050 Q98604751-DF5AEE66-C8E2-4585-85D5-0BF12D9E2480 @default.
- Q98604751 P1050 Q98604751-E0E078BC-C336-482F-ACF1-E76124A79512 @default.
- Q98604751 P1132 Q98604751-BD38D314-4B2E-4AAB-9787-BE66FB8DFCEA @default.
- Q98604751 P1476 Q98604751-4B167101-E1D9-4412-A054-B96861B3B801 @default.
- Q98604751 P17 Q98604751-C09670E3-5D5D-41C1-9263-1671E09DEF14 @default.
- Q98604751 P2899 Q98604751-92273816-25C6-4AC3-BCEE-ADEBF3BAB804 @default.
- Q98604751 P3098 Q98604751-BAD631AC-CC65-4143-893F-C51D26DAF2BE @default.
- Q98604751 P31 Q98604751-A8AF2175-E389-447D-80B4-CFF0D59DF347 @default.
- Q98604751 P4844 Q98604751-7D85BFD5-109D-4A18-94EE-6D7CC52235DB @default.
- Q98604751 P580 Q98604751-DC3BE60F-D043-4E0A-86DE-ABC304539E57 @default.
- Q98604751 P582 Q98604751-0C90103E-72EE-4C8C-88F3-C185CBC13AD6 @default.
- Q98604751 P6099 Q98604751-C0611FD5-1FB8-48F0-ACD1-E61B297427D3 @default.
- Q98604751 P6153 Q98604751-F49A6A1E-68B7-443A-BFE1-1EB6F0A85BEE @default.
- Q98604751 P8005 Q98604751-4CB95D71-1A5E-40E2-ADE9-9FB5001B8F4B @default.
- Q98604751 P8363 Q98604751-C6262C62-689E-408E-90C3-A00099771B14 @default.
- Q98604751 P921 Q98604751-83126DF7-9112-434C-AF5A-C8C3AC92E582 @default.
- Q98604751 P921 Q98604751-B58ADBFC-5325-4682-A8CE-61B5C3F39079 @default.
- Q98604751 P921 Q98604751-FBE81F65-8689-4171-A591-2E60F832B316 @default.
- Q98604751 P1050 Q179630 @default.
- Q98604751 P1050 Q179945 @default.
- Q98604751 P1050 Q657193 @default.
- Q98604751 P1132 "+70" @default.
- Q98604751 P1476 "Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome" @default.
- Q98604751 P17 Q38 @default.
- Q98604751 P2899 "+18" @default.
- Q98604751 P3098 "NCT04469829" @default.
- Q98604751 P31 Q30612 @default.
- Q98604751 P4844 Q422232 @default.
- Q98604751 P580 "2020-08-01T00:00:00Z" @default.
- Q98604751 P582 "2021-12-31T00:00:00Z" @default.
- Q98604751 P6099 Q42825046 @default.
- Q98604751 P6153 Q2531629 @default.
- Q98604751 P8005 Q76649614 @default.
- Q98604751 P8363 Q78089383 @default.
- Q98604751 P921 Q10566551 @default.
- Q98604751 P921 Q179945 @default.
- Q98604751 P921 Q422232 @default.